1. Home
  2. ICUI vs LAUR Comparison

ICUI vs LAUR Comparison

Compare ICUI & LAUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • LAUR
  • Stock Information
  • Founded
  • ICUI 1984
  • LAUR 1989
  • Country
  • ICUI United States
  • LAUR United States
  • Employees
  • ICUI N/A
  • LAUR N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • LAUR Other Consumer Services
  • Sector
  • ICUI Health Care
  • LAUR Real Estate
  • Exchange
  • ICUI Nasdaq
  • LAUR Nasdaq
  • Market Cap
  • ICUI 3.0B
  • LAUR 3.5B
  • IPO Year
  • ICUI 1992
  • LAUR 2017
  • Fundamental
  • Price
  • ICUI $133.13
  • LAUR $29.28
  • Analyst Decision
  • ICUI Buy
  • LAUR Buy
  • Analyst Count
  • ICUI 6
  • LAUR 1
  • Target Price
  • ICUI $186.60
  • LAUR $24.00
  • AVG Volume (30 Days)
  • ICUI 314.3K
  • LAUR 799.7K
  • Earning Date
  • ICUI 11-11-2025
  • LAUR 10-30-2025
  • Dividend Yield
  • ICUI N/A
  • LAUR N/A
  • EPS Growth
  • ICUI N/A
  • LAUR 35.40
  • EPS
  • ICUI N/A
  • LAUR 1.68
  • Revenue
  • ICUI $2,372,504,000.00
  • LAUR $1,552,343,000.00
  • Revenue This Year
  • ICUI N/A
  • LAUR $5.64
  • Revenue Next Year
  • ICUI N/A
  • LAUR $8.10
  • P/E Ratio
  • ICUI N/A
  • LAUR $17.25
  • Revenue Growth
  • ICUI 2.96
  • LAUR 0.44
  • 52 Week Low
  • ICUI $107.00
  • LAUR $14.49
  • 52 Week High
  • ICUI $196.26
  • LAUR $29.07
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 60.24
  • LAUR 78.47
  • Support Level
  • ICUI $121.61
  • LAUR $27.05
  • Resistance Level
  • ICUI $136.61
  • LAUR $28.05
  • Average True Range (ATR)
  • ICUI 3.76
  • LAUR 0.61
  • MACD
  • ICUI 1.09
  • LAUR 0.05
  • Stochastic Oscillator
  • ICUI 78.47
  • LAUR 98.45

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About LAUR Laureate Education Inc.

Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.

Share on Social Networks: